Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan E Alpert

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Journal of Clinical Psychopharmacology|July 3, 2004
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorderGeorge I Papakostas, Dan V Iosifescu, Timothy Petersen, et al.
The International Journal of Neuropsychopharmacology|September 14, 2004
Obesity among outpatients with major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy J Petersen, Dan V Iosifescu, et al.
The Journal of Clinical Psychiatry|November 2, 2005
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorderGeorge I Papakostas, Timothy J Petersen, Gustavo Kinrys, et al.
Psychiatric Services (Washington, D.C.)|August 2, 2013
Interprofessional differences in disposition decisions: results from a standardized web-based patient assessmentTristan Gorrindo, Elizabeth Goldfarb, Lydia Chevalier, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
A survey of five antidepressant properties influencing clinician's treatment choices in MDDGeorge I Papakostas, Lindsay A Hallett, Juliana Smith, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorderGeorge I Papakostas, Timothy J Petersen, Roy H Perlis, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
The Journal of Clinical Psychiatry|September 16, 2016
Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care SettingJustin A Chen, Benjamin G Shapero, Nhi-Ha T Trinh, et al.
Journal of Clinical Psychopharmacology|November 13, 2004
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineJonathan E Alpert, George Papakostas, David Mischoulon, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Journal of Clinical Psychopharmacology|July 3, 2004
Serum cholesterol in the continuation phase of pharmacotherapy with fluoxetine in remitted major depressive disorderGeorge I Papakostas, Dan V Iosifescu, Timothy Petersen, et al.
The International Journal of Neuropsychopharmacology|September 14, 2004
Obesity among outpatients with major depressive disorderGeorge I Papakostas, Timothy Petersen, Dan V Iosifescu, et al.
The Journal of Clinical Psychiatry|May 4, 2004
Somatic symptoms as predictors of time to onset of response to fluoxetine in major depressive disorderGeorge I Papakostas, Timothy J Petersen, Dan V Iosifescu, et al.
The Journal of Clinical Psychiatry|November 2, 2005
Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive disorderGeorge I Papakostas, Timothy J Petersen, Gustavo Kinrys, et al.
Psychiatric Services (Washington, D.C.)|August 2, 2013
Interprofessional differences in disposition decisions: results from a standardized web-based patient assessmentTristan Gorrindo, Elizabeth Goldfarb, Lydia Chevalier, et al.
Neuropsychiatric Disease and Treatment|March 21, 2009
A survey of five antidepressant properties influencing clinician's treatment choices in MDDGeorge I Papakostas, Lindsay A Hallett, Juliana Smith, et al.
Journal of Clinical Psychopharmacology|April 25, 2006
A survey of antidepressant prescribing practices in major depression with comorbid attention-deficit hyperactivity disorderGeorge I Papakostas, Timothy J Petersen, Roy H Perlis, et al.
The Journal of Clinical Psychiatry|August 25, 2004
Serum folate, vitamin B12, and homocysteine in major depressive disorder, Part 1: predictors of clinical response in fluoxetine-resistant depressionGeorge I Papakostas, Timothy Petersen, David Mischoulon, et al.
The Journal of Clinical Psychiatry|September 16, 2016
Association Between Stigma and Depression Outcomes Among Chinese Immigrants in a Primary Care SettingJustin A Chen, Benjamin G Shapero, Nhi-Ha T Trinh, et al.
Journal of Clinical Psychopharmacology|November 13, 2004
S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxineJonathan E Alpert, George Papakostas, David Mischoulon, et al.
Pageof 14